Advert - AbbVie – Case AUTH/3493/3/21

• Date posted
  21 June 2022
• Sanction
  Advertisement,
• Case number/s
  AUTH/3493/3/21 - Complainant v AbbVie

For promoting Durysta (sustained release bimatoprost implant) on LinkedIn, prior to the grant of its marketing authorisation, AbbVie was ruled in breach of the following clauses of the 2019 Code:

Clause 2           - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry

Clause 3.1        - Promoting an unlicensed medicine

Clause 9.1        - Failing to maintain high standards